MON-537 Primary Adrenal Insufficiency During Tyrosine Kinase Inhibitors Treatment in Advanced Thyroid Cancer Patients

Objective: Tyrosine kinase inhibitors (TKIs) are used for the treatment of metastatic differentiated (DTC), poorly differentiated (PDTC) and medullary (MTC) thyroid cancer. Several adverse events (AEs) have been reported in almost all patients (pts) treated with TKIs. One of the less known AE relate...

Descripción completa

Detalles Bibliográficos
Autores principales: Valerio, Laura, Matrone, Antonio, Agate, Laura, Bottici, Valeria, Viola, David, Cappagli, Virginia, Giani, Carlotta, Molinaro, Eleonora, Elisei, Rossella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Thyroid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209016/
http://dx.doi.org/10.1210/jendso/bvaa046.1647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209016/
http://dx.doi.org/10.1210/jendso/bvaa046.1647

Ejemplares similares